ABSTRACT
We describe an innovative interventional technique for the repair of a postoperative enterocutaneous fistula (ECF). In the reported case, surgical repair of the ECF was contraindicated, while endoscopic closure was unsuccessful. Correction of this high-outflow fistula was achieved using an Amplatzer septal occluder, which was deployed under simultaneous fluoroscopic and endoscopic guidance. The use of an Amplatzer septal occluder should be taken into consideration when there is a need to treat high-outflow ECF in patients who cannot undergo surgery.
Subject(s)
Catheterization/instrumentation , Duodenal Diseases/therapy , Intestinal Fistula/therapy , Postoperative Complications/therapy , Endoscopy/methods , Fatal Outcome , Fluoroscopy , Humans , Intestinal Obstruction/surgery , Male , Middle Aged , Radiography, InterventionalABSTRACT
Secondary lymphoma of the breast is a rare entity in patients with non-Hodgkin's lymphoma (NHL). HIV infection is associated with an increased risk for developing NHL, however lymphomatous involvement of the breast in AIDS patients has rarely been reported. We present the case of a 33-year-old HIV-infected female patient with diffuse NHL who presented with a unilateral breast mass. Histologic examination of the biopsy specimen revealed a highly-malignant diffuse large B-cell lymphoma.
Subject(s)
Breast Neoplasms/secondary , HIV Infections/complications , Lymphoma, Large B-Cell, Diffuse/pathology , Adult , Biopsy , Breast Neoplasms/complications , Breast Neoplasms/pathology , Breast Neoplasms/virology , Female , Humans , Lymphoma, Large B-Cell, Diffuse/complications , Lymphoma, Large B-Cell, Diffuse/virologyABSTRACT
The management of cervical intraepithelial neoplasia (CIN(2-3)) diagnosed during pregnancy was the subject of this study. Two hundred and eight pregnant women with an abnormal cytology were assessed in our unit over a 10-year period. The age of the patients ranged from 20 to 45 (mean 28) years. Seventy-eight of these women were histologically proven to have CIN(2-3). All patients were followed up every 8-10 weeks by cytology and colposcopy during pregnancy and reassessed 8-12 weeks postpartum. The disease persisted in 30 cases (38.4%), whereas in the remaining 48 cases it regressed to CIN(1). No case of invasive disease developed during the follow-up period in these pregnant patients. Conservative management of CIN(2-3) during pregnancy is acceptable, but close follow-up and colposcopic expertise are necessary.
